Skip to content

Clinical trials

Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Completed Country / region: Netherlands Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20031
20053
20081
20092
20101
20111
20124
20133
20142
20152
20161
20172
20182
20202
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group5
Novartis Pharmaceuticals5
Amgen3
Amgen Research (Munich) GmbH2
Bristol-Myers Squibb2
European Organisation for Research and Treatment of Cancer - EORTC2
Gamida Cell ltd2
medac GmbH2
AbbVie1
Allotera Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma37
Leukemia11
Leukemia, Myeloid, Acute8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Neoplasms5
Recurrence5
Myelodysplastic Syndromes4
Burkitt Lymphoma3
Hematologic Neoplasms3
Lymphoproliferative Disorders3

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.